US: puts focus on diagnostics regulation, reimbursement
This article was originally published in Clinica
AdvaMed has launched a five-year campaign to demonstrate the value of clinical laboratory tests and promoted its chief press spokesman, Jeff Ezell, to run the initiative. While innovation in the diagnostics area is rapid, regulation and reimbursement for new tests worldwide has not kept pace, threatening patient access and future innovation, the association maintains.
You may also be interested in...
While good clinical practice inspectors in the UK and the US collaborate on matters of common interest, they say that mutual recognition is simply not possible.
Last year, Mallinckrodt attempted restructuring the firm to evade bankruptcy fears. However, the company is now filing for bankruptcy for its US generics business to address “unmanageable liabilities.”
Informa Pharma Intelligence has officially launched the seventh Global Generics & Biosimilars Awards, which will take place in October 2020 in Milan, Italy.